As of November 6, 2026, Cardiff Oncology, Inc. is a publicly traded company (Nasdaq: CRDF). The largest insider holding is Gary W. Pace, a director, with 2,043,661 shares (2.6% of shares outstanding), per Form 4 of July 16, 2026. No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13G, July 29, 2025).
Is this your company?
About to sign with, pay or invest in Cardiff Oncology, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Cardiff Oncology, Inc. a real, registered company?
- Cardiff Oncology, Inc. files with the SEC under CIK 1213037 (its SEC filings).
- Its shares are listed under the ticker CRDF on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in San Diego, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Cardiff Oncology, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Leila Alland, Chief Medical Officer (Form 8-K filed 2026-10-27). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Vanguard (filed 2025-07-29).
Who are Cardiff Oncology, Inc.'s owners and officers?
Cardiff Oncology, Inc.: incorporated in Delaware; business address in San Diego, California; industry Biological Products, (No Diagnostic Substances) (Form D, 2026-10-27).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-07-27 | Blackrock, Inc. | 1.3% |
| Schedule 13G/A, 2026-03-26 | The Vanguard Group | 0% |
| Schedule 13G/A, 2025-08-14 | Commodore Capital LP | 0% |
| Schedule 13G, 2025-07-29 | The Vanguard Group | 5.6% |
Want the whole picture on Cardiff Oncology, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Cardiff Oncology, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Cardiff Oncology, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-10-27 | Leila Alland | Chief Medical Officer | appointed | |
| Form 8-K, 2026-04-09 | Josh Muntner | Chief Financial Officer | appointed | 2026-04-06 |
Which insiders own Cardiff Oncology, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director: 2,043,661 shares (2.6% of shares outstanding) (Form 4, 2026-07-16).
- , the chief financial officer: 67,716 shares (0.09% of shares outstanding), held indirectly through a wife (Form 4, 2024-12-18).
- , the chief executive and a director: 59,067 shares (0.08% of shares outstanding) (Form 4, 2026-07-16).
- , the chief accounting officer: 27,431 shares (0.04% of shares outstanding) (Form 3, 2026-02-09).
- , a director: 20,000 shares (0.03% of shares outstanding) (Form 4, 2024-12-16).
Shares outstanding: 77,795,249 as of 2026-08-06, from the company's latest SEC cover page.
How much has Cardiff Oncology, Inc. raised?
No fundraising or offering filing from Cardiff Oncology, Inc. is on file with us.
Keep reading
More on Cardiff Oncology, Inc. and the records around it.
Cardiff Oncology, Inc. elsewhere on the record
- Leadership changes Apr 2026
Companies that share a holder
- Commodore Capital LP also filed stake reports on 40 other companies: Sagimet Biosciences Inc. (Oct 2026), Surrozen, Inc./DE (Oct 2026), JATT III Acquisition Corp (Sep 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/cardiff-oncology